BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16258500)

  • 1. Dual-color, break-apart fluorescence in situ hybridization for EWS gene rearrangement distinguishes clear cell sarcoma of soft tissue from malignant melanoma.
    Patel RM; Downs-Kelly E; Weiss SW; Folpe AL; Tubbs RR; Tuthill RJ; Goldblum JR; Skacel M
    Mod Pathol; 2005 Dec; 18(12):1585-90. PubMed ID: 16258500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of EWS break-apart fluorescence in situ hybridization in distinguishing between non-cutaneous melanoma and clear cell sarcoma.
    Song JS; Choi J; Kim JH; Jang SJ; Cho KJ
    Pathol Int; 2010 Sep; 60(9):608-13. PubMed ID: 20712646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-color, break-apart fluorescence in situ hybridization probe for distinguishing clear cell sarcoma of soft tissue from malignant melanoma.
    Yoon JH; Baek YS; Jeon J; Oh CH; Song HJ
    Int J Dermatol; 2014 Dec; 53(12):1464-7. PubMed ID: 25312298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and characterization of EWSR1/ATF1 and EWSR1/CREB1 chimeric transcripts in clear cell sarcoma (melanoma of soft parts).
    Wang WL; Mayordomo E; Zhang W; Hernandez VS; Tuvin D; Garcia L; Lev DC; Lazar AJ; López-Terrada D
    Mod Pathol; 2009 Sep; 22(9):1201-9. PubMed ID: 19561568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts).
    Langezaal SM; Graadt van Roggen JF; Cleton-Jansen AM; Baelde JJ; Hogendoorn PC
    Br J Cancer; 2001 Feb; 84(4):535-8. PubMed ID: 11207050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell sarcoma of soft tissue: diagnostic utility of fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction.
    Curry CV; Dishop MK; Hicks MJ; Naeem R; Reed JA; López-Terrada DH
    J Cutan Pathol; 2008 Apr; 35(4):411-7. PubMed ID: 18333903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of specific gene rearrangements by fluorescence in situ hybridization in 16 cases of clear cell sarcoma of soft tissue and 6 cases of clear cell sarcoma-like gastrointestinal tumor.
    Segawa K; Sugita S; Aoyama T; Kubo T; Asanuma H; Sugawara T; Ito Y; Tsujiwaki M; Fujita H; Emori M; Hasegawa T
    Diagn Pathol; 2018 Sep; 13(1):73. PubMed ID: 30219084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of EWSR1 gene rearrangement by fluorescence in situ hybridization in bone and soft tissue tumors: clinical application evaluation and atypical signal analysis].
    Li L; Zhang M; Zhang TT; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):458-463. PubMed ID: 38678326
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of EWS-FLI-1 fusion in Ewing's sarcoma/peripheral primitive neuroectodermal tumor by fluorescence in situ hybridization using formalin-fixed paraffin-embedded tissue.
    Kumar S; Pack S; Kumar D; Walker R; Quezado M; Zhuang Z; Meltzer P; Tsokos M
    Hum Pathol; 1999 Mar; 30(3):324-30. PubMed ID: 10088552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnosis of Ewing sarcoma/primitive neuroectodermal tumor in routinely processed tissue: a comparison of two FISH strategies and RT-PCR in malignant round cell tumors.
    Bridge RS; Rajaram V; Dehner LP; Pfeifer JD; Perry A
    Mod Pathol; 2006 Jan; 19(1):1-8. PubMed ID: 16258512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.
    Yamaguchi U; Hasegawa T; Morimoto Y; Tateishi U; Endo M; Nakatani F; Kawai A; Chuman H; Beppu Y; Endo M; Kurotaki H; Furuta K
    J Clin Pathol; 2005 Oct; 58(10):1051-6. PubMed ID: 16189150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
    Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
    J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
    Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
    Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and molecular spectrum of ewing sarcomas/PNETs, including validation of EWSR1 rearrangement by conventional and array FISH technique in certain cases.
    Rekhi B; Vogel U; Basak R; Desai SB; Jambhekar NA
    Pathol Oncol Res; 2014 Jul; 20(3):503-16. PubMed ID: 24293381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of clear cell sarcoma by real-time reverse transcriptase-polymerase chain reaction analysis of paraffin embedded tissues: clinicopathologic and molecular analysis of 44 patients from the French sarcoma group.
    Coindre JM; Hostein I; Terrier P; Bouvier-Labit C; Collin F; Michels JJ; Trassard M; Marques B; Ranchere D; Guillou L
    Cancer; 2006 Sep; 107(5):1055-64. PubMed ID: 16878328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of routine histology, immunohistochemistry, reverse transcriptase polymerase chain reaction, and fluorescence in situ hybridization in diagnosis of Ewing family of tumors.
    Jambhekar NA; Bagwan IN; Ghule P; Shet TM; Chinoy RF; Agarwal S; Joshi R; Amare Kadam PS
    Arch Pathol Lab Med; 2006 Dec; 130(12):1813-8. PubMed ID: 17149955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiation.
    Antonescu CR; Nafa K; Segal NH; Dal Cin P; Ladanyi M
    Clin Cancer Res; 2006 Sep; 12(18):5356-62. PubMed ID: 17000668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma of the soft parts (clear-cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation.
    Speleman F; Delattre O; Peter M; Hauben E; Van Roy N; Van Marck E
    Mod Pathol; 1997 May; 10(5):496-9. PubMed ID: 9160316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral clear cell sarcoma of soft tissue with confirmation by EWS-ATF1 fusion detection.
    Granville L; Hicks J; Popek E; Dishop M; Tatevian N; Lopez-Terrada D
    Ultrastruct Pathol; 2006; 30(1):111-8. PubMed ID: 16517477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.